These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39149499)

  • 1. Chromogranin A Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling.
    Mahata S; Jati S; Munoz-Mayorga D; Shahabi S; Tang K; Tao Y; Dickson D; Litvan I; Ghosh G; Chen X
    Res Sq; 2024 Aug; ():. PubMed ID: 39149499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromogranin A (CgA) Deficiency Attenuates Tauopathy by Altering Epinephrine-Alpha-Adrenergic Receptor Signaling.
    Jati S; Munoz-Mayorga D; Shahabi S; Tang K; Tao Y; Dickson DW; Litvan I; Ghosh G; Mahata SK; Chen X
    bioRxiv; 2024 Jun; ():. PubMed ID: 38915622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.
    Barron MR; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC
    Front Immunol; 2020; 11():293. PubMed ID: 32194553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAD-biosynthetic enzyme NMNAT1 reduces early behavioral impairment in the htau mouse model of tauopathy.
    Rossi F; Geiszler PC; Meng W; Barron MR; Prior M; Herd-Smith A; Loreto A; Lopez MY; Faas H; Pardon MC; Conforti L
    Behav Brain Res; 2018 Feb; 339():140-152. PubMed ID: 29175372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
    Komuro Y; Xu G; Bhaskar K; Lamb BT
    Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nogo-A Drives Alzheimer's Disease Progression by Inducing Tauopathy Vulnerability.
    Wang Z; Pan JP; Geng J; Lv S; Chen G; Fang N; Zhang Z; Li J; Xu X; Wang R; Zheng Q; Yan L; Chen G; Xiao F
    Aging Dis; 2024 May; ():. PubMed ID: 38916730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbial DNA and immune checkpoint gene Vsig4/CRIg are key antagonistic players in healthy aging and age-associated development of hypertension and diabetes.
    Liu MA; Shahabi S; Jati S; Tang K; Gao H; Jin Z; Miller W; Meunier FA; Ying W; van den Bogaart G; Ghosh G; Mahata SK
    Front Endocrinol (Lausanne); 2022; 13():1037465. PubMed ID: 36440192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Chromogranin A deficiency on catecholamine storage, catecholamine granule morphology and chromaffin cell energy metabolism in vivo.
    Pasqua T; Mahata S; Bandyopadhyay GK; Biswas A; Perkins GA; Sinha-Hikim AP; Goldstein DS; Eiden LE; Mahata SK
    Cell Tissue Res; 2016 Mar; 363(3):693-712. PubMed ID: 26572539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tau Isoform-Driven CBD Pathology Transmission in Oligodendrocytes in Humanized Tau Mice.
    Zareba-Paslawska J; Patra K; Kluzer L; Revesz T; Svenningsson P
    Front Neurol; 2020; 11():589471. PubMed ID: 33519674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of CSF chromogranin A to discriminate between Alzheimer's disease and dementia with Lewy bodies.
    Bousiges O; Lavaux T; Demuynck C; Schaeffer-Agalède C; Philippi N; Muller C; Cretin B; Blanc F
    Neuropathol Appl Neurobiol; 2024 Feb; 50(1):e12961. PubMed ID: 38363175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole Genome Expression Analysis in a Mouse Model of Tauopathy Identifies MECP2 as a Possible Regulator of Tau Pathology.
    Maphis NM; Jiang S; Binder J; Wright C; Gopalan B; Lamb BT; Bhaskar K
    Front Mol Neurosci; 2017; 10():69. PubMed ID: 28367114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.
    Emmerson JT; Malcolm JC; Do Carmo S; Nguyen P; Breuillaud L; Martinez-Trujillo JC; Cuello AC
    Neurobiol Dis; 2023 Oct; 187():106317. PubMed ID: 37802153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PINK1 Alleviates Cognitive Impairments
    Jiang XJ; Wu YQ; Ma R; Chang YM; Li LL; Zhu JH; Liu GP; Li G
    Front Cell Dev Biol; 2021; 9():736267. PubMed ID: 35059394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triggering receptor expressed on myeloid cells 2 deficiency exacerbates injury-induced inflammation in a mouse model of tauopathy.
    Katsumoto A; Kokiko-Cochran ON; Bemiller SM; Xu G; Ransohoff RM; Lamb BT
    Front Immunol; 2022; 13():978423. PubMed ID: 36389767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
    Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
    Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
    Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
    J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired burrowing is the most prominent behavioral deficit of aging htau mice.
    Geiszler PC; Barron MR; Pardon MC
    Neuroscience; 2016 Aug; 329():98-111. PubMed ID: 27167086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroartemisinin Induces O-GlcNAcylation and Improves Cognitive Function in a Mouse Model of Tauopathy.
    Xia L; Pang Y; Li J; Wu B; Du Y; Chen Y; Luo M; Wang Y; Dong Z
    J Alzheimers Dis; 2021; 84(1):239-248. PubMed ID: 34511503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.